DAIC

MARCH 13, 2024

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty. In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. and published simultaneously in JAMA , the team reports that pa

Angioplasty 116

Angioplasty Stents Stent Myocardial Infarction 116

HCPLive

MARCH 13, 2024

In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.

COVID-19 115

COVID-19 Sickle Cell Disease Hospital 115

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced Centers for Medicare & Medicaid Services (CMS) approval for reimbursement coverage of the confirmatory Phase III clinical trial of CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Med Page Today

MARCH 13, 2024

(MedPage Today) -- Note that some links may require registration or subscription. These types of medications don't mix well with driving, the FDA warned. About 11% of high school seniors reported using delta-8-tetrahydrocannabinol (delta-8-THC.

Heart Attack 107

Heart Attack Heart attacks 107

Cardiovascular Diabetology

MARCH 13, 2024

The association of the triglyceride-glucose (TyG) index with intracranial atherosclerotic stenosis (ICAS) and extracranial atherosclerotic stenosis (ECAS) is unclear. This study aimed to investigate the relati.

Stenosis 105

Stenosis Research 105

Med Page Today

MARCH 13, 2024

(MedPage Today) -- Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes on subcutaneous liraglutide.

Peripheral Arterial Disease 102

Peripheral Arterial Disease Diabetes 102

DAIC

MARCH 13, 2024

Silence Therapeutics has announces positive topline 36-week data from its ongoing Phase 2 Study of Zerlasiran in patients with high Lipoprotein(a), reporting that the study met the primary endpoint and demonstrated highly significant reductions in Lp(a) to week 36. Image courtesy: Silence Therapeutics christine.book Wed, 03/13/2024 - 13:00 March 13, 2024 — Silence Therapeutics has announced positive topline 36-week data from the ongoing ALPACAR-360 phase 2 study of zerlasiran ( SLN360 ) in 178 s

Cardiovascular Disease 98

Cardiovascular Disease Risk Factors Cholesterol Heart attacks 98

Dr. Smith's ECG Blog

MARCH 13, 2024

Written by Willy Frick A man in his early 40s with BMI 36, hypertension, and a 30 pack-year smoking history presented with three days of chest pain. It started while he was at rest after finishing a workout. He described it as a mild intensity, nagging pain on the right side of his chest with nausea and dyspnea. It woke him the next day and radiated into his back.

Chest Pain 88

Chest Pain Angina Echocardiogram Myocardial Infarction 88

Science Daily - Heart Disease

MARCH 13, 2024

Researchers from ETH Zurich and KUNO Klinik St. Hedwig in Regensburg have developed an algorithm that provides an automatic and reliable method of detecting a certain heart defect in newborns. Researchers from ETH Zurich and KUNO Klinik St. Hedwig in Regensburg have developed an algorithm that provides an automatic and reliable method of detecting a certain heart defect in newborns.

Research 78

Research 78

The New England Journal of Medicine

MARCH 13, 2024

A 55-year-old man had an out-of-hospital cardiac arrest. An evaluation showed 2-mm ST-segment elevations in the inferior leads on electrocardiography, cardiogenic shock, and a new systolic murmur. A diagnosis was made.

Cardiogenic Shock 75

Cardiogenic Shock Cardiac Arrest Hospital 75

Nature Reviews - Cardiology

MARCH 13, 2024

Nature Reviews Cardiology, Published online: 14 March 2024; doi:10.1038/s41569-024-01010-4 Novel cardiovascular therapeutics have the potential to improve health outcomes, but financial toxicity from high out-of-pocket costs can limit the reach of these medications and worsen existing health disparities. Understanding the phenomenon of financial toxicity in treating cardiovascular disease is crucial to achieving health equity.

Health Disparities 75

Health Disparities Cardiovascular Disease Outcomes 75

The New England Journal of Medicine

MARCH 13, 2024

In this podcast episode, host Lisa Rosenbaum talks with two trainees whose lives and careers have been changed by educational debt, and to an economist who has a rather different take on the problem.

Education 75

Education 75

Becker's Hospital Review - Cardiology

MARCH 13, 2024

Morristown, N.J.-based Atlantic Health System's Morristown Medical Center and New York City-based NYU Langone Health expanded their partnership to include adult congenital heart disease services.

Congenital Heart Disease 69

Congenital Heart Disease Congenital Heart Disease 69

American College of Cardiology

MARCH 13, 2024

Gilbert H. L. Tang, MD, MSc, MBA, FACC, has been selected as the next editor-in-chief of JACC: Case Reports. He will officially assume the role of editor-in-chief on Aug. 1, with his first issue slated for Aug. 7.

Article 73

Article 73

CardiacWire

MARCH 13, 2024

The hottest drug class in the world just got even hotter after the FDA approved Novo Nordisk’s weight-loss drug Wegovy for cardiovascular event risk reduction, opening new cardiology-focused routes for GLP-1 care and coverage. Wegovy’s expanded FDA approval now supports its use for the reduction of major adverse cardiovascular events in obese or overweight adults with established CVD.

Obesity 64

Obesity Diabetes Heart attacks Heart Attack 64

HCPLive

MARCH 13, 2024

Alexis discusses clinical and demographic hurdles in treating skin of color for conditions like atopic dermatitis, and the potential of research like that being done in tapinarof cream 1%.

Research 64

Research 64

ADN Center of Excellence

MARCH 13, 2024

In the ever-changing environment of healthcare, one thing remains constant: the need for continuous learning and adaptation. The field of medicine is rapidly evolving, with new discoveries, technologies, and therapies arriving on a daily basis. In this blog, we'll focus at how continuing medical education is more than simply a professional requirement; it's also a catalyst for good change, altering healthcare throughout the world.

Education 59

Education Innovation Best Practices Patient Care 59

HCPLive

MARCH 13, 2024

Now, 4 years since the start of the pandemic, how has sleep been impacted? Sleep experts provide their perspective.

COVID-19 78

COVID-19 78

Frontiers in Cardiovascular Medicine

MARCH 13, 2024

Peripartum Cardiomyopathy (PPCM) is a polymorphic myocardial disease occurring late during pregnancy or early after delivery. While reduced systolic function and heart failure (HF) symptoms have been widely described, there is still a lack of reports about the arrhythmic manifestations of the disease. Most importantly, a broad range of unidentified pre-existing conditions, which may be missed by general practitioners and gynecologists, must be considered in differential diagnosis.

Cardiomyopathy 59

Cardiomyopathy Sudden Cardiac Death Outpatient Arrhythmia 59

HCPLive

MARCH 13, 2024

A new study suggests a next-generation stool DNA test from Exact Sciences has improved sensitivity for colorectal cancer and precancerous lesions but lower specificity than FIT.

Cancer 59

Cancer 59

Med Page Today

MARCH 13, 2024

(MedPage Today) -- In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone, the Chinese randomized.

Stroke 59

Stroke Strokes 59

HCPLive

MARCH 13, 2024

Saeed Mohammed, MD, MS, discusses maralixibat for pruritus in PFIC, describing how IBAT inhibitors have changed the way clinicians are able to treat cholestatic liver disease.

59

59

Science Daily - Heart Disease

MARCH 13, 2024

Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heart attacks and strokes, which are the most common causes of death worldwide. The complex mechanisms that lead to pathological changes in the arteries are not yet fully understood. An international research team has now made important progress in understanding this disease and identified potential new approaches for early detection and therapy.

Heart Attack 58

Heart Attack Heart attacks Stroke Strokes 58

HCPLive

MARCH 13, 2024

In an interview with HCPLive, Daniel Karlin, MD, discussed how their phase 2B trial demonstrated MM120’s durability through week 12 for the treatment of generalized anxiety disorder.

59

59

NEJM Journal Watch - Cardiology

MARCH 13, 2024

In patients with angina and no obstructive coronary disease, positive stress tests were highly predictive of CMD.

Angina 75

Angina 75

HCPLive

MARCH 13, 2024

Treatment with DAA therapy at 3 years of age was associated with better health outcomes and cost savings versus deferring initiation to 6 years of age or older.

Outcomes 59

Outcomes 59

ADN Center of Excellence

MARCH 13, 2024

In the ever-changing environment of healthcare, one thing remains constant: the need for continuous learning and adaptation. The field of medicine is rapidly evolving, with new discoveries, technologies, and therapies arriving on a daily basis. In this blog, we'll focus at how continuing medical education is more than simply a professional requirement; it's also a catalyst for good change, altering healthcare throughout the world.

Education 52

Education Innovation Best Practices Patient Care 52

Society of Thoracic Surgeons - Congenital

MARCH 13, 2024

Event Heart Valve Disease Forum 2024 kchalko Wed, 03/13/2024 - 08:19 Event dates Aug 30–31, 2024 Mayfield Hotel, Seoul, Korea Location Seoul, Korea STS is pleased to co-present the Heart Valve Disease Forum (HVDF) with the Korean Society for Thoracic and Cardiovascular Surgery, offering the latest knowledge regarding the basics, diagnosis, treatment, and future of valvular heart disease.

Heart Valves 52

Heart Valves Aortic valve Cardiovascular Surgery Academic 52

Journal of Cardiothoracic Surgery

MARCH 13, 2024

Chest wall chondrosarcomas, although common, pose unique challenges due to their aggressive nature, rarity of abdominal wall involvement, and propensity for recurrence. We highlight the critical role of meticu.

Innovation 52

Innovation 52

Open Heart

MARCH 13, 2024

Objectives To describe the incidence of acute aortic dissection in a clearly defined population, to assess onset symptoms and admission biochemical marker levels and to analyse variables potentially associated to mortality. Methods Medical records and CT angiograms of all patients hospitalised for acute aortic dissection in the Stockholm County during the 5-year period 2012–2016 were reviewed.

Aortic 52

Aortic Outcomes 52

HCPLive

MARCH 13, 2024

Iptacopan monotherapy improved hematologic outcomes in both anti-C5–treated patients with persistent anemia and those not treated with complement inhibitors across two phase 3 trials.

Outcomes 52

Outcomes 52

Open Heart

MARCH 13, 2024

Objective To investigate the time to first childbirth and to compare the prevalence of assisted reproductive treatment (ART) in women with congenital heart disease (CHD) compared with women without CHD. Methods All women in the national register for CHD who had a registered first childbirth in the Swedish Pregnancy Register between 2014 and 2019 were identified.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Risk Factors 52

DAIC

MARCH 13, 2024

New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care. Shown here, Trish O’Keefe, Senior Vice President, and President of Morristown Medical Center.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Cancer 52

Open Heart

MARCH 13, 2024

Importance Although cardiac injury is a known complication of COVID-19 infection, there is no established tool to predict cardiac involvement and in-hospital mortality in this patient population. Objective To assess if left ventricular global longitudinal strain (LV-GLS) can detect cardiac involvement and be used as a risk-stratifying parameter for hospitalised patients with COVID-19.

COVID-19 52

COVID-19 Hospital Outcomes 52

HCPLive

MARCH 13, 2024

Dr April W. Armstrong reviews key findings from the phase 3 POETYK PSO-1 and POETYK PSO-2 clinical trials evaluating the use of deucravacitinib for the treatment of plaque psoriasis.

Plaque 52

Plaque 52

Physiologically Speaking

MARCH 13, 2024

Within exercise and sports science, no one measure has gotten more attention than VO2 max. VO2 max refers to your maximum rate of oxygen consumption, and it’s typically measured during a maximal exercise test to exhaustion (they’re not fun, trust me). It is used as an indicator of an individual's cardiorespiratory fitness and is often used to demonstrate the effects of training.

Exercise 52

Exercise Physiology Research Biomarkers 52

American College of Cardiology

MARCH 13, 2024

In this week’s View, Dr. Eagle covers various blood pressure parameters and their predictability for peripheral arterial disease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers.

Blood Pressure 56

Blood Pressure Pacemaker Peripheral Arterial Disease Heart Failure 56